Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1993
06/29/1993USRE34299 Psychological disorders, neuroleptic agents, analgesics
06/29/1993US5223510 Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them
06/29/1993US5223501 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists
06/29/1993US5223271 Lithium treatment
06/29/1993CA1319684C Ergolinyl compounds nitrogen-substituted in the 8- position, their preparation, and use as medicinal agents
06/29/1993CA1319612C Iron-calcium mineral supplements with enhanced bioavailability
06/28/1993CA2085844A1 Fused benzeneoxyacetic acid derivatives
06/27/1993CA2086026A1 Bisphosphonate derivative
06/27/1993CA2075346A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
06/24/1993WO1993012251A1 Senescent cell derived inhibitors of dna synthesis
06/24/1993WO1993012146A1 Trophoblast interferons and their use
06/24/1993WO1993012142A1 Cytokines with an unpaired cysteine residue and conjugates thereof
06/24/1993WO1993012085A1 Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
06/24/1993WO1993012081A1 20-methyl-substituted vitamin d derivates
06/24/1993WO1993011797A1 Drug containing an atriopeptidase inhibitor and at least one calcic antagonist
06/24/1993WO1993011786A1 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone
06/24/1993WO1993011781A1 Synthetic compounds and compositions with enhanced cell binding
06/24/1993WO1993011761A1 Aryl-triflates and related compounds
06/24/1993WO1993011760A1 Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
06/24/1993WO1993011755A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
06/24/1993WO1993011668A1 Methods and compositions for reducing multi-drug resistance
06/24/1993WO1993009791A3 Use of amphotericin b derivatives as protease inhibitors
06/24/1993CA2126242A1 Aryl-triflates and related compounds
06/24/1993CA2125279A1 Methods and compositions for reducing multi-drug resistance
06/24/1993CA2125181A1 Trophoblast interferons and their use
06/24/1993CA2124826A1 Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
06/24/1993CA2124672A1 Cytokines with an upaired cysteine residue and conjugates thereof
06/23/1993EP0547708A1 Saccharin derivative proteolytic enzyme inhibitors
06/23/1993EP0547705A1 Pharmacologically active tricyclic benzotriazepine derivatives
06/23/1993EP0547687A1 17B-N-Substituted adamantyl/norbonanyl carbamoyl-4-aza-5a-and-rost-1-en-3-ones and androstan-3 ones
06/23/1993EP0547672A2 Inhibitors of farnesyl protein transferase
06/23/1993EP0547671A2 Inhibitors of farnesyl protein transferase
06/23/1993EP0547670A2 Inhibitors of farnesyl protein transferase
06/23/1993EP0547669A2 Inhibitors of farnesyl protein transferase
06/23/1993EP0547558A1 Use of aminoguanidine for the manufacture of a medicament for inhibiting nitric oxide formation
06/23/1993EP0547545A1 Pharmaceutical composition for the inhibition of bone resorption
06/23/1993EP0547517A1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation
06/23/1993EP0547514A2 Imidazopyridine derivatives with angiotensin-II antagonist properties
06/23/1993EP0547442A1 Dihydropyrimidin derivatives used as A-II receptor antagonists
06/23/1993EP0547334A1 Combination of calcium antagonists with cholinesterase inhibitors for the treatment of senile demention
06/23/1993EP0547234A1 Remedy for osteoporosis
06/23/1993EP0547179A1 Triarylethylene carboxylic acids with estrogenic activity
06/23/1993EP0547172A1 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR
06/23/1993EP0547151A1 TREATMENT PROCESS FOR PROMOTING WEIGHT LOSS EMPLOYING A SUBSTITUTED $g(D)5-ANDROSTENE
06/23/1993CN1073439A Amorphous (quinolin-2-ylmethoxy) indoles
06/23/1993CN1073427A Mono-fluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase
06/23/1993CN1073357A Tocotrienols and tocotrienol-like compounds and methods for their use
06/23/1993CN1073335A Air treatment plant for foodstuffs
06/23/1993CN1021323C Process for preparing antidepressants
06/22/1993US5221789 Interferon-gamma receptor fragment and its production
06/22/1993US5221752 α-keto amide derivatives
06/22/1993US5221678 Cardiovascular disorders, antiinflammatory agents, antiallergens
06/22/1993US5221677 For treating diseases mediated by leukotrienes
06/22/1993CA1319364C Fused heterocyclic compounds
06/22/1993CA1319323C Medicaments for the treatment of emesis
06/22/1993CA1319322C Azelastine-containing medicaments for application in the nose and/or eye
06/22/1993CA1319321C Pharmaceutical preparations
06/21/1993CA2085656A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
06/20/1993CA2084857A1 Saccharin derivative proteolytic enzyme inhibitors
06/19/1993CA2085705A1 Pharmacologically active tricyclic derivatives
06/19/1993CA2085456A1 17beta-n-substituted adamantyl/norbornanyl carbamoyl-4-aza-5a -androst -1-en-3-ones and adrostan-3-ones as 5a-reductase inhibitors
06/19/1993CA2085094A1 Imidazopyridines
06/17/1993DE4141746A1 20-methyl-substituierte vitamin d-derivate 20-methyl-substituted vitamin d derivatives
06/17/1993CA2085557A1 Dihydropyrimidine derivatives
06/17/1993CA2085421A1 Pharmaceutical composition for the inhibition of bone resorption
06/17/1993CA2085399A1 Method for inhibiting nitric oxide formation
06/17/1993CA2085283A1 Inhibitors of farnesyl protein transferase
06/17/1993CA2085282A1 Inhibitors of farnesyl protein transferase
06/17/1993CA2084796A1 Inhibitors of farnesyl protein transferase
06/17/1993CA2084795A1 Inhibitors of farnesyl protein transferase
06/16/1993EP0547000A1 Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound
06/16/1993EP0546870A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression
06/16/1993EP0546593A1 Multi-layered compositions containing histamine or serotonin antagonists
06/16/1993EP0546389A1 Piperidylmethyl substituted chroman derivatives as agents for the treatment of diseases of the central nervous system
06/16/1993EP0546388A1 Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system
06/16/1993EP0546125A1 Osteogenic factor
06/16/1993EP0546118A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
06/16/1993EP0546115A1 Peptides containing amino-polyols as transition-state mimics
06/16/1993EP0546108A1 Pro-drugs for cck antagonists
06/16/1993EP0546102A1 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases.
06/16/1993EP0546081A1 New insulin-like growth factor binding protein (igfbp-4)
06/16/1993EP0546068A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy
06/16/1993EP0546063A1 Toxic agent protective compounds, compositions and uses
06/16/1993EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
06/16/1993EP0546007A1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients.
06/16/1993EP0545972A1 Therapeutically active mixture of glutathion and anthocyan compounds.
06/16/1993EP0545946A1 Growth-promoting agent
06/16/1993EP0308500B1 Human somatomedin carrier protein subunits and process for producing them
06/16/1993EP0290558B1 Antifolate agents
06/16/1993CN1073174A Heterocyclic derivatives
06/16/1993CN1073171A Derivative of quinoline, its preparation process and its application in medical treatment
06/16/1993CN1073166A Derivative of hydroximic acid
06/16/1993CN1073161A Endothelin receptor antagonists
06/16/1993CN1021223C Process for 5-lipoxygense inhibiting 4-(4-phenyl-1-pip-erazing 1) phenols
06/15/1993US5220059 An N-amino-, hydroxy or thiocarbonyl or thiocarbonyl, N-hydroxyaminoalkylene derivative
06/15/1993US5219886 Cardiovascular disorders, analgesics, enzyme inhibitors
06/15/1993US5219872 Treating Alzheimer*s disease, memory disorders
06/15/1993US5219864 Thienopyridine derivatives
06/15/1993US5219862 Dopaminergic agents
06/15/1993US5219849 Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma
1 ... 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 ... 1564